Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents

被引：6

作者：

Corvino, Angela ^{[1
]}

Rosa, Roberta ^{[2
]}

Incisivo, Giuseppina Maria ^{[1
]}

Fiorino, Ferdinando ^{[1
]}

Frecentese, Francesco ^{[1
]}

Magli, Elisa ^{[1
]}

Perissutti, Elisa ^{[1
]}

Saccone, Irene ^{[1
]}

Santagada, Vincenzo ^{[1
]}

Cirino, Giuseppe ^{[1
]}

Riemma, Maria Antonietta ^{[1
]}

Temussi, Piero A. ^{[3
]}

Ciciola, Paola ^{[2
]}

Bianco, Roberto ^{[2
]}

Caliendo, Giuseppe ^{[1
]}

Roviezzo, Fiorentina ^{[1
]}

Severino, Beatrice ^{[1
]}

机构：

[1] Univ Naples Federico II, Sch Med, Dept Pharm, I-80131 Naples, Italy

[2] Univ Naples Federico II, Div Oncol, Dept Clin Med & Surg, I-80131 Naples, Italy

[3] Kings Coll London, Wohl Inst, 5 Cutcombe Rd, London SE5 9RT, England

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 11期

关键词：

Sphingosine Kinase 1; Sphingosine Kinase 2; inhibitors; synthesis; antiproliferative activity; CANCER; DESIGN; SPHK;

D O I：

10.3390/ijms18112332

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Two series of N-(aryl)-1-(hydroxyalkyl)pyrrolidine-2-carboxamides (2a-2g and 3a-3g) and 1,4-disubstituted 1,2,3-triazoles (5a-5h and 8a-8h) were synthesized. All the compounds, containing a lipophilic tail and a polar headgroup, were evaluated as sphingosine kinase (SphK) inhibitors by assessing their ability to interfere with the acetylcholine (Ach) induced relaxation of aortic rings pre-contracted with phenylephrine. Moreover, their antiproliferative activity was tested on several cell lines expressing both SphK1 and SphK2. Compounds 5h and 8f, identified as the most efficient antiproliferative agents, showed a different selectivity profile, with 8f being selective for SphK1.

引用

页数：18

共 26 条

[1] Sphingosine Kinases: Emerging Structure-Function Insights
Adams, David R.
Pyne, Susan
Pyne, Nigel J.
[J]. TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (05) : 395 - 409
[2] Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720
Allende, ML
Sasaki, T
Kawai, H
Olivera, A
Mi, YD
van Echten-Deckert, G
Hajdu, R
Rosenbach, M
Keohane, CA
Mandala, S
Spiegel, S
Proia, RL
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) : 52487 - 52492
[3] Structure-Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors
Baek, Dong Jae
MacRitchie, Neil
Anthony, Nahoum G.
Mackay, Simon P.
Pyne, Susan
Pyne, Nigel J.
Bittman, Robert
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 9310 - 9327
[4] Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity
Childress, Elizabeth S.
Kharel, Yugesh
Brown, Anne M.
Bevan, David R.
Lynch, Kevin R.
Santos, Webster L.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (09) : 3933 - 3957
[5] Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II
Cingolani, Francesca
Casasampere, Mireia
Sanllehi, Pol
Casas, Josefina
Bujons, Jordi
Fabrias, Gemma
[J]. JOURNAL OF LIPID RESEARCH, 2014, 55 (08) : 1711 - 1720
[6] Sphingosine kinase 1 as an anticancer therapeutic target
Gao, Ying
Gao, Fei
Chen, Kan
Tian, Mei-li
Zhao, Dong-li
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3239 - 3245
[7] Structure guided design of a series of sphingosine kinase (SphK) inhibitors
Gustin, Darin J.
Li, Yihong
Brown, Matthew L.
Min, Xiaoshan
Schmitt, Mike J.
Wanska, Malgorzata
Wang, Xiaodong
Connors, Richard
Johnstone, Sheere
Cardozo, Mario
Cheng, Alan C.
Jeffries, Shawn
Franks, Brendon
Li, Shyun
Shen, Shanling
Wong, Mariwil
Wesche, Holger
Xu, Guifen
Carlson, Timothy J.
Plant, Matthew
Morgenstern, Kurt
Rex, Karen
Schmitt, Joanna
Coxon, Angela
Walker, Nigel
Kayser, Frank
Wang, Zhulun
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (16) : 4608 - 4616
[8] Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, Gregory T.
Maceyka, Michael
Milstien, Sheldon
Spiegel, Sarah
[J]. NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (09) : 688 - 702
[9] SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism
Maceyka, M
Sankala, H
Hait, NC
Le Stunff, H
Liu, H
Toman, R
Collier, C
Zhang, M
Satin, LS
Merrill, AH
Milstien, S
Spiegel, S
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (44) : 37118 - 37129
[10] Sphingolipid metabolites in inflammatory disease
Maceyka, Michael
Spiegel, Sarah
[J]. NATURE, 2014, 510 (7503) : 58 - 67

← 1 2 3 →